Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

Hirsutism in teens is often due to polycystic ovarian syndrome and needs careful assessment and support.

PCOS is a common hormonal disorder with symptoms like irregular periods and excess hair growth, managed with lifestyle changes and medications.

The document concludes that alopecia has various forms, each with specific treatments, but no definitive cure for certain types like CCCA has been proven.

Women with PCOS are much more likely to have sleep problems and should be checked for them.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Losing weight and eating better are key to managing metabolic syndrome and its related conditions.

Many women with hard-to-treat acne also have PCOS.

Early diagnosis and personalized treatment are crucial for managing hair loss in children.

Inhaled substances in e-cigarettes can cause hormone imbalances similar to congenital adrenal hyperplasia.

Different PCOS characteristics affect lipid profiles, increasing cardiovascular disease risk, so regular lipid screening is advised.

Metformin works better for adolescent girls with PCOS who have certain genetic variations.

The guideline refines PCOS diagnosis, promotes a healthy lifestyle, reviews treatments, and stresses long-term follow-up.

PCOS symptoms can improve with specific treatments for pituitary adenomas.

The new rodent model successfully mimics non-lean human PCOS symptoms.

Weight loss improves PCOS symptoms and overall health.

Microglia, the brain's immune cells, may contribute to Polycystic Ovary Syndrome (PCOS) by altering the female brain's structure and function, with kisspeptin neurons and GABA neurotransmitters also playing a role.

Most women with excessive hair growth (hirsutism) also experience a common type of non-scarring hair loss called Androgenetic alopecia with telogen effluvium.

ABO/Rh blood groups are not a risk factor for PCOS.

The Exfoliate-Dissolve-Repair skincare approach may effectively treat keratosis pilaris and reduce the need for corticosteroids.

The TT/DHT ratio may help identify PCOS patients with severe metabolic issues.

A rare benign ovarian tumor was found in a pregnant woman, but both mother and baby remained healthy.

Most women with hirsutism have mild symptoms and often experience acne, menstrual irregularities, and obesity.

Obese women with PCOS have more cardiovascular risk factors, and waist-to-stature ratio is a better health marker than waist-to-hip ratio.

Androgen measurement helps diagnose PCOS, but accuracy varies, needing standard methods.

PCOS affects health and quality of life, with effective treatments available and a need for more research on alternative therapies.

Excessive hair growth affects the quality of life of Iranian women with PCOS the most.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.